• Ayisha Raja
  • Shoaib Naiyar Hashmi
  • Nadra Sultana
  • Haroon Rashid


Background: This study was carried out to determine the pattern of presentation of Polycysitc ovary syndrome (PCOS) in patients presenting at our unit and to compare effects of clomiphene alone and in combination with metformin in management of PCOS. Methods: This study was conducted was conducted from Jan 2001-2003 at Military Hospital, Rawalpindi. All patients presenting with infertility were evaluated with a view to select 100 patients of PCOS with the help of history of oligomenorrhoea, hirsuitism and acne. Diagnosis was confirmed by ultrasonography and hormone analysis (LH, FSH, prolactin, testosterone along with LH:FSH>2). The 100 selected patients were divided into two equal groups, one was given combined clomiphene citrate (CC) and metformin for ovulation induction and the other CC alone. These patients were followed for six cycles for ovulation and conception. Follicle tracking on ultrasonography and day-21 serum progesterone level were used to detect ovulation while conception was confirmed by urine pregnancy test, serum B - HCG level and ultrasonography for gestational sac. Results: Hirsuitism and oligomenorrhoea were the two most common clinical features of PCOS. In the first group 34 patients (68%) ovulated as compared with 18 (36%) in the second group. In the first group 18 out of 34 women (52.9 %) conceived as compared with only 8 out of 18 (44%) in the second group. The difference was significant at >0.05 when ovulatory and pregnancy responses were compared among two groups. All patients tolerated metformin well and no teratogenic effects were observed in patients who conceived after treatment with metformin. Conclusion: A combination of metformin and clomiphene citrate significantly increases the ovulation and conception rates in these patients.KEY WORDS:     PCOS, metformin, ovulation induction.


Balen A. Induction of Ovulation. In: Johnson IR, Arulkumaran S, Nelson- Piercy C, Shafi M, Ledger W, Rubin PC, et al eds. Current obstetrics and gynaecology. London: Churchill Livingston; 2001:233-8.

Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333:853-61.

Erickson GF, Yen SSC. The polycystic ovary syndrome. In Adashi E, Leung Pck, eds. The ovary. New York: Raven; 1993 : 561-80.

Goldzieher JW. Polycystic ovarian disease. Fertile steril 1981;35:371-94.

Mekenna TJ. Pathogenesis and treatment of polycystic ovary syndrome. N Engl J Med 1988:318:558

Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800.

Diamanti - kandarakls E, Kouli C, Tsiaoateli T, Bergiele A. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur J Endocrinol 1998;138:269 – 74.

Nestler JE, Jakubowiez DJ, Ewans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998;338:1876-80.

Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181-5.

Goldzieher JW, Axelrod LR. Clinical and biochemical features of polycystic ovarian disease. Fertile steril 1963;14:631-53.

Baler AH, Conway GS, Kaltsas G. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995;10:2107-11.

Fauzia N, Shagufta S, Maryum M, Huma A, Saadat A, Saad R. Polycystic ovary syndrome - diagnosis and management in fertility deprivation. Pak J obstet Gynecol 1999;12(1,2):59-71.

Lobo RA, Carmina E. Polycystic ovary syndrome. In : Lobo RA, Mishell DR, Paulson RJ, Shoupe D, eds. Mishell's textbook of infertility, contraception and reproductive endocrinology. 4th ed. London:Blackwell Science;1997:363-78.

Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, eds. Polycystic ovary syndrome: Current Issues in Endocrinology and Metabolism, Vol 4. Boston, Blackwell Scientific 1992;377-384.

Yen SS, Vela P, Rankin J. Inappropriate secretion of follicle - stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metabol 1970;30:435-42.

Lobo RA, Granger L, Goebelsmann U. Elevation in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO. J Clin Endocrinol Metabol 1981;52:156-8.

Corenblum B. Hyperprolactinemic polycystic ovary syndrome. In: Mahesh VB, Greenblatt RB, eds. Hirsutism and virilism. Littleton, Mass: John Wright - PSG, Inc. 1983;239-46.

Daniel SAJ, Armstrong DT. Androgens in the ovarian microenvironment. Seminars in Reproductive Endocrinology 1986;4:89.

Fox R, Corrigan E, Thomas PA. The diagnosis of polycystic ovaries in women with oligomenorrhoea: Predictive power of endocrine tests. Clin Endocrinol 1991;34:127.

Balen AH. The pathogenesis of polycystic ovary syndrome: the enigma unravels. Editorial. Lancet 1999;354 : 966 - 7.

Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989;38:1165-74.

Kidson W. Polycystic ovary syndrome: a new direction in treatment. Med J Aust 1999:169:537- 40.

Maria JI, Nestler JE. Insulin - lowering drugs in polycystic ovary syndrome. Obstet Gynaecol Clin North Amer 2001;28: 153-64.

Vandermolen DT, Ratts VS, Evans WS, Stoval DW, Karma SW, Nestler JE. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil steril 2001;75:392-5.

Malikawi HY, Hussain S, Qublan. The effect of metformin plus clomiphene citrate on ovulation and pregnancy rates in clomiphene-resistant women with polycystic ovary syndrome. Saudi Med J 2002;23(6):663-6.

Imtiaz SA, Khan FA, Farid S, Yasmeen S, Nizamani T. Metformin induced resumption of menses, ovulation and subsequent pregnancy in hyperinsulaemic Polycytic ovarian disease. Annals KEMC 2002;8(3):177-8.